Zobrazeno 1 - 10
of 67
pro vyhledávání: '"N I Korshunov"'
Autor:
L. N. Denisov, E. S. Tsvetkova, E. N. Otteva, A. N. Dubikov, S. P. Yakupova, O. N. Ivanova, N. I. Korshunov, А. P. Vaisberg, R. A. Abyshev, А. V. Tartynov, E. L. Nasonov
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 56-60 (2018)
Objective. To assess the efficacy and safety of amtolmetin guacil (AMG) in patients with knee joint osteoarthritis (KJOA) and associated dyspepsia in real clinical practice.Methods. 220 patients with KJOA with severe pain syndrome in KJ ≥ 40 mm in
Externí odkaz:
https://doaj.org/article/af76dea524c24f5a8a8b884ca2f3302b
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 1, Pp 93-98 (2018)
The review considers the problem of comorbidity of osteoarthritis (OA) and depression. The latter in OA patients is shown to be commonly a component of the well-known triad of pain – depression – sleep disorders, frequently determining the functi
Externí odkaz:
https://doaj.org/article/d2452fca97344fffb1c500e4e7089680
Autor:
E. S. Tsvetkova, L. N. Denisov, A. N. Otteva, A. L. Dubikov, S. P. Yakupova, O. N. Ivanova, N. I. Korshunov, A. R. Vaisberg, R. A. Abyshev, A. V. Tartynov, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 6, Pp 654-659 (2017)
Objective: to investigate the efficacy and tolerability of amtolmetin guacil (AMG; Niselat®, Dr. Reddy's Laboratories Ltd, India) versus previous therapy with nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with knee osteoarthritis (OA) an
Externí odkaz:
https://doaj.org/article/0fc0f5fa7d27486eb4cbb5a7a88d624f
Publikováno v:
Терапевтический архив, Vol 88, Iss 5, Pp 27-31 (2016)
Aim. To study attitude towards the disease in rheumatic patients during antidepressant therapy and during further follow-up. Subjects and methods. Examinations were made in 122 patients with degenerative joint and vertebral column disease (DJVCD) and
Externí odkaz:
https://doaj.org/article/53b3fb55af8f4671939e2a819c98ffc5
Publikováno v:
Научно-практическая ревматология, Vol 53, Iss 5, Pp 469-471 (2015)
Externí odkaz:
https://doaj.org/article/f65f50608f7d4090a4c02cbd237c7d6b
Autor:
Dmitry Evgenyevich Karateev, E L Nasonov, L N Denisov, M L Stanislav, E Yu Panasyuk, I A Andrianova, V I Mazurov, E S Zhugrova, Yu P Uspensky, L N Belousova, E P Ilivanova, G K Matsiyevskaya, G P Aurtyunov, K A Lytkina, R S Saikovsky, V N Ardashev, E V Zhilyaev, N I Korshunov
Publikováno v:
Научно-практическая ревматология, Vol 50, Iss 2, Pp 14-19 (2012)
Certolizumab pegol (CZP) is a new drug from the group of tumor necrosis factor a inhibitors. The efficacy and safety CZP in the treatment of rheumatoid arthritis (RA) have been studied in the international 52-week RAPID-1 and 24-week RAPID-2 clinical
Externí odkaz:
https://doaj.org/article/101a52e2f0e349c78a5f2b4e52dc7d4f
Publikováno v:
Современная ревматология, Vol 3, Iss 2, Pp 85-88 (2009)
Externí odkaz:
https://doaj.org/article/4caa103e11ff4a2bac67c7aea08ce4ed
Publikováno v:
Научно-практическая ревматология, Vol 47, Iss 1, Pp 43-49 (2009)
Objective. To study comorbid depression influence on course of rheumatoid arthritis (RA)and antidepressants efficacy in such pts. Material and methods. 70 pts with RA (all women) fulfilled the 1987 ACR criteria with comorbid depression disturbances w
Externí odkaz:
https://doaj.org/article/5d7e8f8b4bf34a11937b2c22786219ce
Publikováno v:
Научно-практическая ревматология, Vol 46, Iss 1, Pp 36-48 (2008)
To standardize general quality of life (QL) questionnaire SF-36 scales and calculate population scale measures depending on respondents sex and age. Material and methods. Standardized QL measures of all SF-36 questionnaire scales were calculated in 3
Externí odkaz:
https://doaj.org/article/b9842febcb3d4aa087603262e1a07865
Publikováno v:
Научно-практическая ревматология, Vol 45, Iss 3, Pp 77-80 (2007)
Цель. Установить связь эффективности лечения стационарных больных с заболеваниями опорно-двигательного аппарата с некоторыми личност
Externí odkaz:
https://doaj.org/article/11b5dc61ae1649758e6b39a6c3022a08